High-cost imaging in elderly patients with stage IV cancer

Journal of the National Cancer Institute

Volumn 104, Issue 15, 2012, Pages 1164-1172

  Hu, Yue Yung ^a,b   Kwok, Alvin C ^a   Jiang, Wei ^a   Taback, Nathan ^c   Loggers, Elizabeth T ^c,d   Ting, Gladys V ^a   Lipsitz, Stuart R ^a   Weeks, Jane C ^c   Greenberg, Caprice C ^c,e,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ELDERLY CARE; FEMALE; HEALTH CARE COST; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTISCANNING;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMPARATIVE EFFECTIVENESS RESEARCH; FEMALE; HEALTH CARE COSTS; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEDICARE; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; SEER PROGRAM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84864922238     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs286     Document Type: Article

References (37)

1. Riley GF, Lubitz JD. Long-term trends in Medicare payments in the last year of life. Health Serv Res. 2010;45(2):565-576.
2. Medpac. A Data Book: Healthcare Spending and the Medicare Program. Washington, DC: MPAC; 2010.
3. NCI. Cancer Trends Progress Report-2009/2010 Update. Bethesda, MD: NIH, DHHS; 2010.
4. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-128.
5. Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27(23):3868-3874.
6. Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22(2):315-321. (Pubitemid 41095097)
7. Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010;303(16):1625-1631.
8. Baker LC, Atlas SW, Afendulis CC. Expanded use of imaging technology and the challenge of measuring value. Health Aff (Millwood). 2008;27(6):1467-1478.
9. Medpac. Report to Congress: Aligning Incentives in Medicare. Washington, DC: MPAC; 2010.
10. NCI. About the SEER Program. http://seer.cancer.gov/about/overview.html.
11. NCI. SEER-Medicare Fact Sheet. Health NIo, ed. Bethesda, MD: U.S. National Institutes of Health (NIH); 2009.
12. HCUP. HCUP CCS-Services and Procedures. http://www.hcup-us.ahrq.gov/ toolssoftware/ccs-svcsproc/ccssvcproc.jsp#questions.A.
13. ACGME Case Log CPT/ICD-9 List. http://www.acgme.org/ residentdatacollection/documentation/codelist.asp. Accessed July 8, 2010.
14. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9):630-641.
15. Rousseeuw PJ, Leroy AM. Robust Regression and Outlier Detection. New York, NY: Wiley; 1987.
16. Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004;292(22):2765- 2770. (Pubitemid 39628256)
17. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003;327(7408):195-198. (Pubitemid 36920584)
18. Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006;24(21):3490-3496. (Pubitemid 46638908)
19. Emanuel EJ, Young-Xu Y, Levinsky NG, et al. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med. 2003;138(8):639-643.
20. Roche H, Vahdat LT. Treatment of metastatic breast cancer: second line and beyond. Ann Oncol. 2011;22(5):1000-1010.
21. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22(2):229-237. (Pubitemid 41095086)
22. Massarelli E, Andre F, Liu DD, et al. A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer. 2003;39(1):55-61. (Pubitemid 36020295)
23. Morgensztern D, Waqar S, Subramanian J, et al. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. J Thorac Oncol. 2009;4(12):1524-1529.
24. Cetin K, Beebe-Dimmer JL, Fryzek JP, et al. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology. 2010;75(6):1396-1404.
25. Lang K, Korn JR, Lee DW, et al. Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer. 2009;9:227.
26. Dawood S, Broglio K, Gonzalez-Angulo AM, et al. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol. 2008;26(30):4891-4898.
27. NCCN. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Fort Washington, PA: NCCN. http://www.nccn.org/professionals/physician-gls/pdf/colon. pdf. Accessed February 25, 2011.
28. NCCN. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. http://www.nccn.org/professionals/physician-gls/pdf/rectal.pdf. Accessed February 25, 2011.
29. NCCN. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. http://www.nccn.org/professionals/physician-gls/pdf/breast.pdf. Accessed March 25, 2011.
30. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091-5097. (Pubitemid 46631413)
31. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol. 2004;22(2):330-353. (Pubitemid 41095099)
32. NCCN. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf. Accessed June 21, 2011.
33. Sirovich B, Gallagher PM, Wennberg DE, et al. Discretionary decision making by primary care physicians and the cost of U.S. health care. Health Aff (Millwood). 2008;27(3):813-823. (Pubitemid 351770251)
34. NCCN. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. http://www.nccn.org/professionals/physician-gls/pdf/nscl.pdf. Accessed January 7, 2011.
35. NCCN. NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer. http://www.nccn.org/professionals/physician-gls/pdf/sclc.pdf. Accessed June 23, 2011.
36. Desch CE, Benson AB III, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23(33):8512-8519.
37. Loprinzi CL, Hayes D, Smith T. Doc, shouldn't we be getting some tests? J Clin Oncol. 2003;21(suppl 9):108s-111s.